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background:  Statin treatment is well established for patients with dyslipidemia and high risk for cardiovascular events. Little is known 
about differences in patient profile and LDL target achievement between Europe and China.
Methods:  The cross sectional, observational study DYSIS examined lipid goal attainment among statin-treated very high cardiovascular 
risk patients (defined as per 2011 EAS/ESC guidelines, including patients with coronary heart disease, diabetes, chronic kidney disease or 
peripheral atherosclerotic disease) in Canada, Europe, Middle East and China. Data were collected 2008-2012 under real life conditions in 
physicians’ offices and hospital outpatient wards. We compared the level of LDL-C goal achievement in Europe and China.
Results:  A total of 25,317 patients were enrolled in China and 31,773 in Europe. Chinese patients less often were smokers and less often 
suffered from obesity, diabetes and hypertension, sedentary lifestyle, but more often had prior cerebro-vascular events. In both regions, two 
thirds of patients did not reach the recommended LDL-Chol target <70mg/dl. Chinese patients more often had combined dyslipidemia with 
low HDL-Chol as well as high triglycerides.
conclusion:  Patients treated with statins for secondary prevention in China have a substantially different cardiovascular risk profile as 
compared to European patients. Two thirds of patients in China and Europe do not reach the recommended LDL-Chol target value of < 
70mg/dl in clinical practice.
China
n= 25,317
Europe
n= 31,773 p-value
Age (years) 65.8 65.5 <0.01
Female Gender 48.7 % 43.0 % <0.01
BMI >=30 kg/m2 5.5 % 34.9 % <0.01
Hypertension 65.8 % 77.1% <0.01
Diabetes mellitus 34.7 % 37.8 % <0.01
Smoker (Current / former) 30.0 % 50.1 % <0.01
Sedentary Lifestyle 19.7 % 50.0 % <0.01
Cerebrovascular disease 16.9 % 9.9 % <0.01
Statin = Simvastatin 41.3 % 43.4 % <0.01
Statin = Atorvastatin 41.6 % 33.1 % <0.01
Statin = Rosuvastatin 9.7 % 12.7 % <0.01
LDL-Chol not at goal (<70mg/dl) 66.8 % 64.8 % <0.01
Low HDL-Chol (<40mg/dl in men, <45mg/dl in women) 33.3 % 26.9 % <0.01
TG > 150mg/dl 42.6 % 38.2 % <0.01
